Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced the latest software update for its LungVision® advanced navigation and real-time imaging platform. LungVision® v2.27 introduces Body Vision’s latest AI Tomo® imaging algorithm with a larger field of view, improves the reach and fidelity of the virtual bronchoscopy in peripheral airways, and provides an improved pathway planning experience.
LungVision® uses artificial intelligence (AI) to transform any C-arm fluoroscope into an advanced intraoperative tomographic imaging system with navigational guidance. LungVision’s real-time imaging gives bronchoscopists the confidence to biopsy from small pulmonary lesions with greater speed and precision, maximizing the likelihood for earlier-stage cancer detection and improved lung cancer survival.
Also Read: B-Secur & FIRMINIQ Partner to Revolutionize Heart Health
“Our latest software release provides clinicians with impactful user experience improvements, particularly during peripheral scope navigation, that strengthen their ability to achieve high diagnostic success,” says Matt Baker, CEO of Body Vision Medical. “We look forward to bringing these advancements to our customers across the globe in the coming months.”
Body Vision is demonstrating LungVision® with the latest v2.27 software and the benefits that AI-powered intraoperative imaging offers bronchoscopists in Booth #31 at the American Association for Bronchology and Interventional Pulmonology (AABIP) 2024 Annual Conference taking place August 22-24 at the Sheraton Charlotte Hotel in Charlotte, North Carolina.
Source: PRNewswire
